Covaxin Maker Gets $19 Million For Development Of 'Variant Proof' Vaccine

CEPI on Tuesday said it will provide up to USD 19.3 million (about Rs 149 crore) to Bharat Biotech International, the University of Sydney, and Switzerland-based ExcellGene SA for the development of a...

from NDTV News - Special https://ift.tt/HAad5FK

Comments

Popular posts from this blog

Pak's ISI Fuelling Unrest In Bangladesh, Claims Sheikh Hasina's Son

OnePlus 13s Price in India Leaked Ahead of Launch on June 5

Met Gala 2025: BLACKPINK's Jennie, Rose And Lisa Shine In Style